MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead's Nomination of a Bispecific Research Program

Stock Information for MacroGenics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About MacroGenics Inc.

MacroGenics Provides Update on Corporate Progress and Third Quarter 2023 Financial Results
MacroGenics to Participate in Upcoming Investor Conferences
MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call
MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial Results
MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference Call
MacroGenics Provides Update on Corporate Progress and First Quarter 2023 Financial Results
MacroGenics Announces Date of First Quarter 2023 Financial Results Conference Call
MacroGenics to Participate in Upcoming Investor Conferences

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.